Jio Platforms IPO Set for Tomorrow's Debut Amidst Market Caution and Elevated Crude Prices

Indian markets are trading cautiously today, with the Sensex and Nifty opening lower, primarily influenced by persistently elevated crude oil prices, which are hovering near $115 per barrel, and continued selling by Foreign Institutional Investors. Amidst this broader market apprehension, all eyes are on the highly anticipated stock market debut of Jio Platforms tomorrow, October 28, following its significantly oversubscribed ₹30,213 crore Initial Public Offering. Meanwhile, corporate earnings continue to drive individual stock movements, with Mankind Pharma reporting strong Q2 results and Cipla facing a profit decline.

Key highlights

• Jio Platforms IPO: Shares are set to list tomorrow, October 28, after its ₹30,213 crore IPO was subscribed 22.19 times.
• Indian Equity Markets: Sensex and Nifty opened lower today, driven by elevated crude oil prices and FII selling.
• Crude Oil Prices: Brent crude remains elevated near $115 per barrel, posing a headwind for the Indian economy.
• FII Activity: Foreign Institutional Investors were net sellers, offloading ₹1,462.49 crore in Indian equities on Monday.
• Mankind Pharma: Shares jumped nearly 8% after reporting a 38% year-on-year rise in Q2 profit to ₹716 crore.

Jio Platforms IPO: All Eyes on Tomorrow's Blockbuster Listing

The Indian primary market is abuzz with anticipation as Jio Platforms, the digital and telecom arm of Reliance Industries, prepares for its stock market debut tomorrow, October 28, 2026. The mega ₹30,213 crore Initial Public Offering (IPO) saw an overwhelming response, being subscribed a remarkable 22.19 times overall. The allotment of shares was finalized yesterday, October 26, with shares being credited to investors' demat accounts today, October 27.

The IPO, which was open for subscription from October 21 to October 23, attracted bids worth approximately ₹4.90 lakh crore at the upper end of the price band, setting a new record for investor participation with 1.38 crore applications. Institutional investors showed particularly strong demand, with the Qualified Institutional Buyers (QIB) segment subscribed 70.55 times, while the non-institutional investors (NII) category saw 14 times subscription. The retail individual investor portion was subscribed 2.72 times.

Ahead of its listing, the Grey Market Premium (GMP) for Jio Platforms IPO has been robust, indicating a potential listing gain of around 22%. As of today, October 27, the GMP stood at approximately ₹243-₹254 per share, suggesting an indicative listing price in the range of ₹1,362-₹1,373 against the upper price band of ₹1,119. This strong GMP reflects high market expectations for the company's performance post-listing. The listing process will commence with a special pre-open session from 9 am to 9:45 am, followed by regular trading starting at 10 am on both the BSE and NSE.

Indian Markets Open Lower Amidst Elevated Crude and FII Outflows

Indian equity benchmarks, the Sensex and Nifty, started the trading session on Tuesday, October 27, in negative territory, reflecting a cautious investor sentiment. The Sensex declined over 200 points in early trade, while the Nifty slipped below the 22,700 mark. This downturn comes despite positive cues from Asian markets and an overnight rally on Wall Street, as investors grapple with persistently elevated crude oil prices and continued selling pressure from foreign funds.

A significant factor weighing on the market is the price of crude oil, with Brent crude futures hovering near $115 per barrel. This elevated level of crude prices is a major concern for India, a net oil importer, as it can exacerbate inflation, widen the fiscal deficit, and impact corporate profitability. Although there have been some diplomatic efforts to ease Middle East tensions, fresh attacks on Saudi energy infrastructure have limited any significant decline in oil prices.

Adding to the market's woes, Foreign Institutional Investors (FIIs) continued their selling spree, offloading Indian equities worth ₹1,462.49 crore on Monday, October 26. This consistent outflow of foreign capital has been a recurring theme, contributing to the broader market weakness. Investors are also closely monitoring the upcoming US Federal Reserve's policy decision, expected later this week, for signals on future interest rate trajectories, which could further influence global and domestic market dynamics. The Nifty's monthly expiry today is also expected to contribute to increased volatility in the market.

More stocks and market news

Mankind Pharma Reports Strong Q2 FY27 Earnings, Shares Surge

Mankind Pharma witnessed a significant surge in its share price today, jumping nearly 8% to an intraday high of ₹2,500 on the NSE. This strong performance followed the announcement of its robust Q2 FY27 results, where the company reported a 38% year-on-year increase in consolidated net profit after tax (PAT) to ₹716 crore. Revenue from operations also grew by 17.3% to ₹4,338 crore during the July-September quarter. The company's EBITDA rose 27.2% to ₹1,175 crore, with EBITDA margin improving by 210 basis points to 27.1%. This strong domestic demand, coupled with a 32.7% increase in international revenue, powered the company's impressive quarterly performance.

Tata Motors Clears Key Hurdle in Iveco Takeover Bid

Tata Motors' ambitious acquisition of Italian commercial vehicle maker Iveco Group has moved closer to completion, with its wholly-owned subsidiary, TML CV Holdings B.V., successfully clearing a crucial acceptance threshold. Provisional results indicate that 238.16 million common shares of Iveco Group N.V. were tendered, representing an 89.42% stake (net of treasury shares). This comfortably exceeds the revised 80% threshold required for the offer to become effective, a condition that was automatically reduced from 95% following an extraordinary general meeting on October 16. The aggregate consideration for the tendered shares is approximately €3.43 billion at a revised offer price of €14.40 per share. The final results of the offer are expected to be announced by October 29, with payment for tendered shares scheduled for October 30.

Cipla Reports 35% Decline in Q2 FY27 Net Profit

Pharmaceutical major Cipla announced its Q2 FY27 results today, reporting a significant 35% year-on-year decline in consolidated net profit to ₹878 crore, compared to ₹1,351 crore in the corresponding quarter last year. The company's revenue from operations also saw a marginal decrease of 2.44%, falling to ₹7,404 crore from ₹7,589.44 crore in Q2 FY26. Despite the overall decline, Cipla's domestic 'One-India' business grew 12% year-on-year, and its US business posted $172 million in revenue, continuing its sequential growth. The company expects North America performance to remain supported by its upcoming product pipeline.

Market context

As of 1:32 PM IST, the BSE Sensex was trading at 73,366.29, down 240.46 points or 0.33%, while the NSE Nifty 50 was at 22,696.35, down 56.85 points or 0.25%. Broader markets, however, showed some resilience, with the Nifty Midcap 100 and Nifty Smallcap 100 outperforming the benchmarks. Brent crude oil prices were around $114.80 per barrel, down about 1%, but remained elevated. The Indian Rupee opened slightly stronger at 95.17 against the US Dollar.

Why these stories matter

The impending listing of Jio Platforms signifies a major milestone for India's digital economy, potentially attracting further investment into the technology and telecom sectors. The cautious market sentiment, driven by high crude prices and FII outflows, underscores the ongoing global macroeconomic challenges that continue to influence investor decisions in India. Meanwhile, corporate earnings from key players like Mankind Pharma and Cipla offer crucial insights into sector-specific health and business execution, providing investors with fundamental data points to assess individual company performance amidst broader market trends.

What to watch next

• Jio Platforms Listing: Monitor the listing performance of Jio Platforms on October 28, 2026, for market reaction and price discovery.
• US Federal Reserve Decision: Await the outcome of the US Fed's policy meeting later this week for signals on interest rates and their potential impact on global liquidity and FII flows.
• Crude Oil Movement: Continue to track Brent crude oil prices for any significant shifts, as sustained high prices could further pressure India's economy.
• Remaining Q2 Earnings: Keep an eye on other major companies scheduled to announce Q2 FY27 results, including Larsen & Toubro, Maruti Suzuki, and Bajaj Auto.
• Tata Motors' Iveco Acquisition: Watch for the final results of the Iveco tender offer on October 29 and the subsequent delisting process.

Sources

• HDFC Sky: Tata Power Share Price Rises After BPCL Mumbai Refinery Project MoU
• Livemint: Jio Platforms IPO listing date and time, share price prediction, expected gains, latest GMP; all eyes on NSE, BSE debut
• Economic Times: Jio Platforms IPO GMP: Reliance Industries shares trade lower ahead of Jio Platforms listing scheduled tomorrow
• Rediff.com: Stock Markets Today: Sensex, Nifty Dip on High Crude Prices, IT Sector Woes
• The Hindu: Tata Motors clears key shareholding threshold for takeover of Italian truck maker Iveco

FAQ

1. When is Jio Platforms IPO listing date?

Jio Platforms shares are scheduled to be listed on both the BSE and NSE on Wednesday, October 28, 2026. The listing will follow a special pre-open session from 9 am to 9:45 am, with regular trading commencing at 10 am.

2. What was the subscription status of Jio Platforms IPO?

The Jio Platforms IPO was significantly oversubscribed, with an overall subscription of 22.19 times. The Qualified Institutional Buyers (QIB) segment was subscribed 70.55 times, Non-Institutional Investors (NII) 14 times, and the retail portion 2.72 times.

3. What is the current Grey Market Premium (GMP) for Jio Platforms IPO?

As of October 27, 2026, the Grey Market Premium (GMP) for Jio Platforms IPO ranged from ₹243 to ₹254 per share. This indicates an estimated listing price of approximately ₹1,362 to ₹1,373, representing a potential premium of around 22% over the issue price of ₹1,119.

4. Why are Indian markets trading lower today?

Indian markets are trading lower today due to a combination of factors, including persistently elevated crude oil prices (Brent near $115/barrel), continued selling by Foreign Institutional Investors (FIIs), and caution ahead of the US Federal Reserve's policy decision. FIIs were net sellers of ₹1,462.49 crore on Monday.

5. How did Mankind Pharma perform in Q2 FY27?

Mankind Pharma reported strong Q2 FY27 results, with consolidated net profit after tax (PAT) increasing by 38% year-on-year to ₹716 crore. The company's revenue from operations grew 17.3% to ₹4,338 crore, driven by robust domestic demand and a 32.7% rise in international revenue.

6. What is the latest on Tata Motors' acquisition of Iveco?

Tata Motors' takeover bid for Italian commercial vehicle maker Iveco Group has cleared a key hurdle, with provisional results showing its subsidiary has secured an 89.42% stake. This surpasses the revised 80% acceptance threshold, moving the €3.43 billion acquisition closer to completion.

Disclaimer: This article is for educational purposes only. It does not constitute investment advice. Please consult a SEBI-registered financial advisor before making investment decisions.